Toolkit/Light-Inducible Tuner

Light-Inducible Tuner

Also known as: LITer, LITer gene circuits

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Light-Inducible Tuner (LITer) is a mammalian optogenetic gene-circuit platform in which TetR is fused through the LOV2 light-sensitive domain to either a Tet-inhibitory peptide or a degradation tag. It enables light-controlled negative-feedback regulation of gene expression and was reported to reduce expression noise while providing tunable output control.

Usefulness & Problems

Why this is useful

LITer is useful for achieving more precise optogenetic control of transgene expression in mammalian or human cells, particularly when reduced cell-to-cell variability is important. The source literature states that these circuits should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and related biomedical contexts.

Problem solved

LITer was engineered to address the problem of noisy and insufficiently precise optogenetic gene regulation in mammalian cells. The reported solution is a light-responsive negative-feedback circuit architecture that improves control over expression magnitude while reducing gene expression noise relative to existing optogenetic systems.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Techniques

No technique tags yet.

Target processes

degradation

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedhost context: mammalian cellsimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenimplementation constraint: spectral hardware requirementmammalian context: Truemodality: optogenetic negative-feedback gene circuitnegative feedback: Truenoise reduction: Trueoperating role: actuatoroptogenetic: Trueswitch architecture: multi component

The reported construct architecture uses TetR fused via the LOV2 light-sensitive domain to either a Tet-inhibitory peptide or a degradation tag. The evidence supports implementation as a multi-component optogenetic negative-feedback gene circuit in mammalian cells, but it does not provide practical details such as chromophore requirements, delivery modality, promoter design, or exact light wavelength.

The supplied evidence describes performance in mammalian or human cell gene circuits, but it does not provide broader validation across organisms, tissues, or in vivo settings. The available claims also do not specify illumination parameters, kinetic response characteristics, or comparative performance between the Tet-inhibitory-peptide and degradation-tag variants.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1applicationsupports2019Source 2needs review

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 2applicationsupports2019Source 2needs review

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 3applicationsupports2019Source 2needs review

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 4applicationsupports2019Source 2needs review

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 5applicationsupports2019Source 2needs review

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 6applicationsupports2019Source 1needs review

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 7applicationsupports2019Source 1needs review

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 8applicationsupports2019Source 1needs review

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 9applicationsupports2019Source 1needs review

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 10applicationsupports2019Source 1needs review

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.
Claim 11compositionsupports2019Source 1needs review

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.
Claim 12compositionsupports2019Source 1needs review

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.
Claim 13compositionsupports2019Source 1needs review

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.
Claim 14compositionsupports2019Source 1needs review

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.
Claim 15compositionsupports2019Source 1needs review

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.
Claim 16engineering outcomesupports2019Source 1needs review

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.
Claim 17engineering outcomesupports2019Source 1needs review

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.
Claim 18engineering outcomesupports2019Source 1needs review

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.
Claim 19engineering outcomesupports2019Source 1needs review

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.
Claim 20engineering outcomesupports2019Source 1needs review

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.
Claim 21performancesupports2019Source 2needs review

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control
gene expression control range 4 fold
Claim 22performancesupports2019Source 2needs review

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control
gene expression control range 4 fold
Claim 23performancesupports2019Source 2needs review

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control
gene expression control range 4 fold
Claim 24performancesupports2019Source 2needs review

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control
gene expression control range 4 fold
Claim 25performancesupports2019Source 2needs review

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control
gene expression control range 4 fold
Claim 26performancesupports2019Source 1needs review

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.
gene expression control range 4 foldnoise reduction versus existing optogenetic systems 5 fold
Claim 27performancesupports2019Source 1needs review

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.
gene expression control range 4 foldnoise reduction versus existing optogenetic systems 5 fold
Claim 28performancesupports2019Source 1needs review

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.
gene expression control range 4 foldnoise reduction versus existing optogenetic systems 5 fold
Claim 29performancesupports2019Source 1needs review

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.
gene expression control range 4 foldnoise reduction versus existing optogenetic systems 5 fold
Claim 30performancesupports2019Source 1needs review

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.
gene expression control range 4 foldnoise reduction versus existing optogenetic systems 5 fold
Claim 31performancesupports2019Source 2needs review

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems
noise reduction 5 fold
Claim 32performancesupports2019Source 2needs review

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems
noise reduction 5 fold
Claim 33performancesupports2019Source 2needs review

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems
noise reduction 5 fold
Claim 34performancesupports2019Source 2needs review

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems
noise reduction 5 fold
Claim 35performancesupports2019Source 2needs review

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems
noise reduction 5 fold
Claim 36tool capabilitysupports2019Source 2needs review

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.
Claim 37tool capabilitysupports2019Source 2needs review

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.
Claim 38tool capabilitysupports2019Source 2needs review

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.
Claim 39tool capabilitysupports2019Source 2needs review

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.
Claim 40tool capabilitysupports2019Source 2needs review

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.
Claim 41use casesupports2019Source 1needs review

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.
Claim 42use casesupports2019Source 1needs review

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.
Claim 43use casesupports2019Source 1needs review

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.
Claim 44use casesupports2019Source 1needs review

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.
Claim 45use casesupports2019Source 1needs review

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.

Approval Evidence

2 sources9 linked approval claimsfirst-pass slug light-inducible-tuner
We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.

Source:

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-inhibiting peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.

Source:

applicationsupports

The LITer gene circuit architecture was used to control expression of KRAS(G12V) and study downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.

Source:

applicationsupports

The LITer gene circuit architecture was used to control KRAS(G12V) expression and examine downstream phospho-ERK levels and cellular proliferation.

Moreover, we use the LITer gene circuit architecture to control gene expression of the cancer oncogene KRAS(G12V) and study its downstream effects through phospho-ERK levels and cellular proliferation.

Source:

compositionsupports

The LITer toolset uses TetR fused with either a Tet-Inhibitory peptide or a degradation tag through the LOV2 light-sensitive domain.

We build a toolset of these noise-reducing Light-Inducible Tuner (LITer) gene circuits using the TetR repressor fused with a Tet-Inhibitory peptide (TIP) or a degradation tag through the light-sensitive LOV2 protein domain.

Source:

engineering outcomesupports

The authors engineered optogenetic negative-feedback gene circuits in mammalian cells for noise-reduced precise gene expression control.

Here, we engineer optogenetic negative-feedback gene circuits in mammalian cells to achieve noise-reduction for precise gene expression control.

Source:

performancesupports

LITer circuits provide nearly 4-fold gene expression control.

These LITers provide a range of nearly 4-fold gene expression control

Source:

performancesupports

LITer circuits provide nearly 4-fold gene expression control and up to five-fold noise reduction relative to existing optogenetic systems.

These LITers provide nearly a range of 4-fold gene expression control and up to five-fold noise reduction from existing optogenetic systems.

Source:

performancesupports

LITer circuits reduce gene expression noise by up to 5-fold relative to existing optogenetic systems.

and up to 5-fold noise reduction from existing optogenetic systems

Source:

tool capabilitysupports

LITer gene circuits enable optogenetic negative-feedback control of gene expression in mammalian cells.

Here, we engineer optogenetic gene circuits into mammalian cells to achieve noise-reduction for precise gene expression control by genetic, in vitro negative feedback.

Source:

use casesupports

LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical research fields.

Overall, these novel LITer optogenetic platforms should enable precise spatiotemporal perturbations for studying multicellular phenotypes in developmental biology, oncology, and other biomedical fields of research.

Source:

Comparisons

Source-backed strengths

In the cited studies, LITer circuits provided nearly 4-fold gene expression control and up to 5-fold noise reduction relative to existing optogenetic systems. The platform was also applied to control KRAS(G12V) expression and assess downstream phospho-ERK levels and cellular proliferation, supporting utility in signaling-perturbation experiments.

Ranked Citations

  1. 1.

    Seeded from load plan for claim c3. Extracted from this source document.

  2. 2.
    StructuralSource 2Nucleic Acids Research2019Claim 1Claim 2Claim 3

    Seeded from load plan for claim c1. Extracted from this source document.